Palmitoylation modification of SPI1 promotes nasopharyngeal carcinoma radioresistance through inhibiting c-CBL-mediated ubiquitination and degradation
Drug Resistance Updates · 2026
DOI: 10.1016/j.drup.2026.101374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2026. Verfasst von Li Jiang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China; Department of Toxicolo…. Hauptthemen laut MEDLINE: Radiation Tolerance, Nasopharyngeal Carcinoma, Proto-Oncogene Proteins c-cbl, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Guangxi Medical University, Science Fund for Distinguished Young Scholars of Guangxi Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
AIMS: Radioresistance remains a significant challenge in nasopharyngeal carcinoma (NPC) treatment, resulting in treatment failure and poor clinical outcomes. This study aims to explore and characterize the functional significance and molecular mechanism of SPI1 (a hematopoietic lineage transcription factor) in NPC radioresistance. METHODS: RT-qPCR, Western blot, immunohistochemistry, and immunofluorescence were performed to investigate expression of genes and proteins. Cell viability, apoptosis, migration, and tube formation were determined by MTT, flow cytometry, wound healing, transwell, and tube formation assays. Acyl Biotin Exchange (ABE) assay was used to determine palmitoylation levels of SPI1. Co-immunoprecipitation, chromatin immunoprecipitation, dual-luciferase reporter, EMSA, and RNA pull-down were conducted to analyze the interaction between genes. RESULTS: SPI1 was significantly upregulated in radioresistant NPC tissues and cells, correlating with a poor prognosis. Knockdown of SPI1 suppressed radioresistance in NPC cells and enhanced tumor radiosensitivity in vivo. Palmitoylation of SPI1 at C5 inhibited E3 ubiquitin ligase casitas B-lineage lymphoma (c-CBL)-mediated ubiquitination and degradation, causing SPI1 upregulation in radioresistant NPC cells. SPI1 increased miR-205-5p expression and exosomal enrichment in radioresistant NPC cells, subsequently enhancing endothelial cell angiogenesis. Engineered exosomes carrying miR-205-5p inhibitor suppressed angiogenesis and radioresistance in xenograft models by inhibiting the WW domain-containing protein 2 (WWC2)-mediated Hippo pathway. CONCLUSIONS: Collectively, our findings suggest that SPI1 palmitoylation inhibits c-CBL-mediated ubiquitination and degradation, thereby enhancing SPI1 protein stability and its transcriptional regulation of miR-205-5p. Upregulated miR-205-5p in NPC cells is packaged into exosomes and transferred to endothelial cells, where it targets and inhibits WWC2 expression, eventually promoting angiogenesis and NPC radioresistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China; Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, Guan…
- Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.
- Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China; State Key Laboratory of Targeting Oncology, Guangxi Medical University, Nanning, Guangxi 530…
Förderung
- Guangxi Medical University
- Science Fund for Distinguished Young Scholars of Guangxi Province
- China Postdoctoral Science Foundation
- Natural Science Foundation of Guangxi Province
- Scientific Research and Technology Development Program of Guangxi Zhuang Autonomous Region
- National Natural Science Foundation of China
Zitieren
APA
Jiang, L., Bin, Y., Huang, Y., Wu, L., Qiu, X., Du, Y., Mi, J., Liu, K., Deng, Y., Ning, J., Li, M., Meng, Z., Qin, Y., Zhang, H., Wu, T., Liang, D., Cao, Z., & Kang, M. (2026). Palmitoylation modification of SPI1 promotes nasopharyngeal carcinoma radioresistance through inhibiting c-CBL-mediated ubiquitination and degradation. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101374
Vancouver
Jiang L, Bin Y, Huang Y, Wu L, Qiu X, Du Y, et al. Palmitoylation modification of SPI1 promotes nasopharyngeal carcinoma radioresistance through inhibiting c-CBL-mediated ubiquitination and degradation. Drug Resistance Updates. 2026. doi:10.1016/j.drup.2026.101374
BibTeX
@article{Jiang2026,
author = {Jiang, Li and Bin, Ying and Huang, Yaoyi and Wu, Lanhua and Qiu, Xingyue and Du, Youchang and Mi, Jinglin and Liu, Kang and Deng, Yayan and Ning, Jiancheng and Li, Mingxuan and Meng, Zhen and Qin, Yating and Zhang, Huisi and Wu, Tianyu and Liang, Ding and Cao, Zuoting and Kang, Min},
title = {Palmitoylation modification of SPI1 promotes nasopharyngeal carcinoma radioresistance through inhibiting c-CBL-mediated ubiquitination and degradation},
journal = {Drug Resistance Updates},
year = {2026},
doi = {10.1016/j.drup.2026.101374}
}
EUVIMED